| Autor: |
Kifle, Zemene Demelash, Adinew, Getnet Mequanint, Mengistie, Mestayet Geta, Gurmu, Abyot Endale, Enyew, Engidaw Fentahun, Goshu, Bahiru Tenaw, Amare, Gedefaw Getenet |
| Zdroj: |
Journal of Evidence-Based Complementary & Alternative Medicine (JEBCAM); September 2020, Vol. 25 Issue: 1 |
| Abstrakt: |
Background. The management and control of malaria has become gradually challenging due to the spread of drug-resistant parasites, lack of effective vaccine, and the resistance of vector to insecticides. Consequently, novel agents are urgently needed from different sources including from medicinal plants. In Ethiopia and Uganda, Myrica salicifoliaroot is traditionally claimed for the treatment of malaria. The aim of this study was to evaluate the in vivo antimalarial activity of root crude extract of M salicifolia.Methods. The parasite, Plasmodium bergheiwas used in this study since it is an appropriate parasite that is most commonly used because of its higher accessibility. A 4-day suppressive test was employed to evaluate the antimalarial effect of crude extract against early infection. The curative and prophylactic effect of the crude extract was further tested by Rane’s test and residual infection procedure. Parasitemia, survival time, packed cell volume, body weight, and rectal temperature of mice were used as evaluation parameters. Windows SPSS version 24 was used to analyze the data and analysis of variance followed by Tukey’s honestly significant difference to compare results between groups.Results. The root crude extract of M salicifoliasignificantly (P< .05-.0001) suppressed parasitemia. The crude extract exhibited a chemosuppression of 40.90.Conclusion. The development of new antimalarial agents and the finding supports the traditional claims and previous in vitro studies. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
